Received: 8 October 2020
Accepted: 12 March 2021
First Online: 22 March 2021
: The cantonal ethical board of Bern, Switzerland, has approved this retrospective study. All patients gave their written general informed consent for the evaluation of their data.
: Not applicable.
: JA, IK, CT, LS, GS, OS, and SR declare that they have no competing interests. LC is a Consultant of BMS. FK is a Consultant of Actelion, BMS, Boehringer-Ingelheim, Pfizer. PV is a Consultant/Speaker of MSD, Abbvie, Roche, Pfizer, Sanofi, Gilead, Amgen, Novartis, Grünenthal, Mepha.